Synergistic and Antagonistic Antiproliferative Effects of Ribociclib (Lee011) and Irinotecan (SN38) on Colorectal Cancer Cells

¹Department of Radiation Oncology, E-Da Cancer Hospital, I-Shou University, Kaohsiung, Taiwan, R.O.C.;
²Division of General Surgery, E-Da Hospital, I-Shou University, Kaohsiung, Taiwan, R.O.C.;
³Division of General Surgery, Department of Surgery, E-Da Hospital, I-Shou University, Kaohsiung, Taiwan, R.O.C.;
⁴Bariatric and Metabolic International Surgery Center, E-Da Hospital, I-Shou University, Kaohsiung, Taiwan, R.O.C.;
⁵School of Chinese Medicine for Post Baccalaureate, I-Shou University, Kaohsiung, Taiwan, R.O.C.;
⁶Division of Hematology-Oncology, Department of Internal Medicine, E-Da Hospital, I-Shou University, Kaohsiung, Taiwan, R.O.C.;
⁷Department of Medicine, School of Medicine, I-Shou University, Kaohsiung, Taiwan, R.O.C.;
⁸School of Medicine for International Students and Department of Nursing, School of Medicine, I-Shou University, Kaohsiung, Taiwan, R.O.C.

Correspondence to: Pai-Mei Lin, School of Medicine for International Students and Department of Nursing, School of Medicine, I-Shou University, No.8, Yida Rd., Jiaosu Village Yanchao District, Kaohsiung 82445, Taiwan, R.O.C. Tel: +886 76151100 Ext. 7173, e-mail: paimeilin{at}gmail.com